LYEL Lyell Immunopharma, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $351.6M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $71.0K |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $132.3K |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $449.5K | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $133.5K |
| 2025-Q4 | $0 | $88.4K |
| 2026-Q1 | $25.0M | $264.3K |
| 2026-Q2 | $0 | $40.6K |
| 2026-Q3 | $0 | $211.3K |
| 2026-Q4 | $50.0M | $22.4K |
Bought$75.4M9 buy days
Sold$963.8K47 sell days
Net insider flow+$74.5Mnet buying · 5 years
Latest trade2026-11-10Seely Lynn
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-10 | Sell | Seely Lynn | CEO | 545 | $15.93 | $8.7K | 1 |
| 2026-11-10 | Sell | Bulis Veronica Sanchez | VP | 416 | $15.93 | $6.6K | 1 |
| 2026-11-10 | Sell | Lee Gary K. | Other C-suite | 129 | $15.93 | $2.1K | 1 |
| 2026-11-10 | Sell | Hill Stephen J. | COO | 88 | $15.93 | $1.4K | 1 |
| 2026-11-04 | Buy | ARCH Venture Fund IX, L.P. | 10% owner | 2,321,262 | $10.77 | $25.0M | 1 |
| 2026-11-04 | Buy | BERNS PAUL L | 10% owner | 2,321,262 | $10.77 | $25.0M | 1 |
| 2026-10-12 | Sell | Aguirre Jarrad Mattieu | Other C-suite | 422 | $8.63 | $3.6K | 1 |
| 2026-09-10 | Sell | Shook David | Other C-suite | 500 | $12.70 | $6.4K | 1 |
| 2026-08-21 | Sell | Seely Lynn | CEO | 9,589 | $15.54 | $149.0K | 1 |
| 2026-08-21 | Sell | Lee Gary K. | Other C-suite | 1,457 | $15.54 | $22.6K | 1 |
| 2026-08-21 | Sell | Hill Stephen J. | COO | 989 | $15.54 | $15.4K | 1 |
| 2026-08-10 | Sell | Bulis Veronica Sanchez | VP | 621 | $14.34 | $8.9K | 1 |
| 2026-08-10 | Sell | Seely Lynn | CEO | 390 | $14.34 | $5.6K | 1 |
| 2026-08-10 | Sell | Lee Gary K. | Other C-suite | 131 | $14.34 | $1.9K | 1 |
| 2026-08-10 | Sell | Hill Stephen J. | COO | 89 | $14.34 | $1.3K | 1 |
| 2026-07-17 | Sell | Innovative Cellular Therapeutics Holdings Ltd | 10% owner | 10 | $13.70 | $137 | 1 |
| 2026-07-16 | Sell | Innovative Cellular Therapeutics Holdings Ltd | 10% owner | 10 | $13.73 | $137 | 1 |
| 2026-06-10 | Sell | Shook David | Other C-suite | 1,977 | $12.64 | $25.0K | 1 |
| 2026-05-11 | Sell | Seely Lynn | CEO | 388 | $18.91 | $7.3K | 1 |
| 2026-05-11 | Sell | Bulis Veronica Sanchez | VP | 217 | $18.91 | $4.1K | 1 |
| 2026-05-11 | Sell | Lee Gary K. | Other C-suite | 130 | $18.92 | $2.5K | 1 |
| 2026-05-11 | Sell | Hill Stephen J. | COO | 89 | $18.92 | $1.7K | 1 |
| 2026-03-06 | Buy | ARCH Venture Fund IX, L.P. | 10% owner | 488,090 | $25.61 | $12.5M | 1 |
| 2026-03-06 | Buy | BERNS PAUL L | 10% owner | 488,090 | $25.61 | $12.5M | 1 |
| 2026-02-11 | Sell | Seely Lynn | CEO | 7,455 | $23.39 | $174.4K | 1 |
| 2026-02-11 | Sell | Lee Gary K. | Other C-suite | 1,671 | $23.39 | $39.1K | 1 |
| 2026-02-11 | Sell | Hill Stephen J. | COO | 1,236 | $23.39 | $28.9K | 1 |
| 2026-02-10 | Sell | Seely Lynn | CEO | 438 | $23.12 | $10.1K | 1 |
| 2026-02-10 | Sell | Bulis Veronica Sanchez | VP | 254 | $23.12 | $5.9K | 1 |
| 2026-02-10 | Sell | Lee Gary K. | Other C-suite | 147 | $23.12 | $3.4K | 1 |
| 2026-02-10 | Sell | Hill Stephen J. | COO | 109 | $23.12 | $2.5K | 1 |
| 2025-12-30 | Sell | Bulis Veronica Sanchez | VP | 936 | $32.32 | $30.3K | 1 |
| 2025-12-24 | Sell | Bulis Veronica Sanchez | VP | 1,136 | $38.67 | $43.9K | 1 |
| 2025-11-10 | Sell | Seely Lynn | CEO | 412 | $16.11 | $6.6K | 1 |
| 2025-11-10 | Sell | Bulis Veronica Sanchez | VP | 239 | $16.10 | $3.8K | 1 |
| 2025-11-10 | Sell | Lee Gary K. | Other C-suite | 138 | $16.16 | $2.2K | 1 |
| 2025-11-10 | Sell | Hill Stephen J. | COO | 95 | $16.12 | $1.5K | 1 |
| 2025-08-21 | Sell | Seely Lynn | CEO | 7,257 | $10.54 | $76.5K | 1 |
| 2025-08-21 | Sell | Lee Gary K. | Other C-suite | 1,453 | $10.54 | $15.3K | 1 |
| 2025-08-21 | Sell | Newton Charles W. | CFO | 1,453 | $10.54 | $15.3K | 1 |
| 2025-08-21 | Sell | Hill Stephen J. | COO | 1,004 | $10.54 | $10.6K | 1 |
| 2025-08-12 | Sell | Seely Lynn | CEO | 406 | $10.34 | $4.2K | 1 |
| 2025-08-12 | Sell | Lee Gary K. | Other C-suite | 136 | $10.34 | $1.4K | 1 |
| 2025-08-12 | Sell | Newton Charles W. | CFO | 136 | $10.34 | $1.4K | 1 |
| 2025-08-12 | Sell | Hill Stephen J. | COO | 94 | $10.34 | $972 | 1 |
| 2025-08-11 | Sell | Seely Lynn | CEO | 391 | $10.53 | $4.1K | 1 |
| 2025-08-11 | Sell | Newton Charles W. | CFO | 131 | $10.53 | $1.4K | 1 |
| 2025-08-11 | Sell | Lee Gary K. | Other C-suite | 131 | $10.53 | $1.4K | 1 |
| 2025-08-11 | Sell | Hill Stephen J. | COO | 91 | $10.53 | $958 | 1 |
| 2025-03-31 | Buy | BRAWLEY OTIS W | Director | 35,640 | $0.56 | $20.0K | 1 |
| 2025-03-21 | Buy | Ramachandra Sumant | Director | 200,000 | $0.58 | $116.0K | 1 |
| 2025-03-17 | Buy | Newton Charles W. | CFO | 200,000 | $0.56 | $112.0K | 1 |
| 2025-03-14 | Buy | Seely Lynn | CEO | 175,000 | $0.61 | $106.8K | 1 |
| 2025-03-14 | Buy | Klausner Richard | Director | 158,000 | $0.60 | $94.8K | 1 |
| 2023-08-15 | Sell | Klausner Richard | Director | 58,020 | $2.28 | $132.3K | 1 |
| 2022-09-23 | Sell | Klausner Richard | Director | 11,100 | $6.40 | $71.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| ARCH Venture Fund IX, L.P. | 10% owner | $37.5M | $0 | 2026-11-04 |
| BERNS PAUL L | 10% owner | $37.5M | $0 | 2026-11-04 |
| Seely Lynn | CEO | $106.8K | $446.6K | 2026-11-10 |
| Klausner Richard | Director | $94.8K | $203.3K | 2025-03-14 |
| Newton Charles W. | CFO | $112.0K | $18.1K | 2025-08-21 |
| Ramachandra Sumant | Director | $116.0K | $0 | 2025-03-21 |
| Bulis Veronica Sanchez | VP | $0 | $103.5K | 2026-11-10 |
| Lee Gary K. | Other C-suite | $0 | $91.8K | 2026-11-10 |
| Hill Stephen J. | COO | $0 | $65.2K | 2026-11-10 |
| Shook David | Other C-suite | $0 | $31.3K | 2026-09-10 |
| BRAWLEY OTIS W | Director | $20.0K | $0 | 2025-03-31 |
| Aguirre Jarrad Mattieu | Other C-suite | $0 | $3.6K | 2026-10-12 |
| Innovative Cellular Therapeutics Holdings Ltd | 10% owner | $0 | $274 | 2026-07-17 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2025-03-14 → 2025-03-31 | 5 | $449.5K | 65 | -11.4% (-19.7% raw) | -14.7% (-11.3% raw) | -4.0% (+17.0% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.